Kevin P. McKian

  • Rolling Meadows, IL
  • Hematologist and oncologist
NPI1972512853PAC ID8426052499
Medicare services, 2024
49,181
Medicare patients, 2024
487
Part D claims, 2024
1,054
Clinical trials
4
Hospital affiliations
5
Practice address
3701 Algonquin Rd, Rolling Meadows, IL 60008
Practice phone
Call (847) 437-3312
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

Northwest Oncology and Hematology SC

Rolling Meadows, Illinois

See all 8 affiliations

Find Kevin McKian's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Kevin P. McKian is a hematologist and oncologist in Rolling Meadows, Illinois

Kevin McKian practices at Northwest Oncology and Hematology SC in Rolling Meadows, Illinois.

Kevin McKian's NPI, 1972512853, was assigned on August 7, 2006. Kevin McKian graduated from Southern Illinois University School of Medicine in 2005. Kevin McKian holds Illinois license 036-127475.

NPI and contact details
Medicare PAC ID
8426052499
NPI enumeration date
August 7, 2006
NPI status
Active
Accepts Medicare assignment
Yes
Practice phone
(847) 437-3312
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Male
Estimated age
47
Medical school graduation
2005

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Practice Data; and Doctors and Clinicians National Downloadable File (CMS)

Kevin P. McKian practices at Northwest Oncology and Hematology SC in Rolling Meadows, Illinois

Kevin McKian's primary practice is Northwest Oncology and Hematology SC, at 3701 Algonquin Rd, Rolling Meadows, IL 60008 in Cook County. The practice phone is (847) 437-3312.

  • Northwest Oncology and Hematology SC
    3701 Algonquin Rd, Rolling Meadows, IL 60008 · Cook CountyPhone(847) 437-3312

Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data

Kevin P. McKian is affiliated with 7 sites of care and 1 medical group

Kevin McKian's primary practice is Northwest Oncology and Hematology SC in Rolling Meadows, Illinois. Kevin McKian is also affiliated with Northwest Community Hospital. The medical group on file is Northwest Oncology & Hematology. Dmand AI also links Kevin McKian to 4 more hospitals and 1 group practice or clinic, each named with a free account.

See all 8 affiliations for Kevin McKian

Sources: NPPES NPI Registry (CMS); Dmand AI Practice Data; and Dmand AI Affiliation Data

Dmand AI tracks the EHR system at Kevin P. McKian's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Kevin McKian practices, 6 sites in all. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
Northwest Oncology and Hematology SCAvailable with a free account
+6 more affiliated sitesAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every site where Kevin McKian practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.

Kevin P. McKian is one of 563 hematologists and oncologists in Illinois

Hematology and oncology is Kevin McKian's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dmand AI has Kevin McKian's licenses on file in 2 states: Illinois and Minnesota.

Specialties and state licenses

  • Hematology and oncology, IllinoisPrimaryLicense 036-127475 · taxonomy 207RH0003X
  • Internal medicine, MinnesotaLicense 48703 · taxonomy 207R00000X

Hematologists and oncologists near Kevin McKian

Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Kevin P. McKian billed Medicare for 49,181 services in 2024

CMS data shows 49,181 Medicare services from Kevin McKian across 47 procedure codes in 2024, for 487 Medicare patients. Medicare paid $389,916 for them.

Medicare services, 202449,181
Medicare patients487
Paid by Medicare$389,916
Procedure codes47

Kevin McKian's Medicare services by type, 2023 to 2024

  • 2023
  • 2024
Drugs given in the office
2023: 65,1022024: 40,87937%
Lab and pathology
2023: 4,2432024: 4,4776%
Tests and treatments
2023: 1,9242024: 1,9893%
Office and hospital visits
2023: 1,5192024: 1,5723%
Other services
2023: 222024: 2641100%

Where Kevin McKian's Medicare services took place, 2024

  • In an office49,026100%
  • In a facility1550%

Kevin McKian compared with the Illinois median for hematologists and oncologists, 2024

  • Kevin McKian
  • Illinois median
Medicare services
49,181vs 1,05646.6 times
Medicare patients
487vs 28273% above
Part D claims
815vs 3282.5 times

Medians across 547 hematologists and oncologists in Illinois with Dmand AI profiles that report each measure.

Kevin McKian's most billed Medicare procedure codes, 2024

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Kevin McKian

Need commercial claims for Kevin McKian?

Medicare shows one payer. Book a meeting to get commercial claims data for Kevin McKian and other hematologists and oncologists in Illinois.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Kevin P. McKian treated 487 Medicare patients in 2024, average age 74

CMS counts 487 Medicare patients who saw Kevin McKian in 2024. The largest group is 65 to 74, with 218 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 11% are also on Medicaid. Their average risk score is 2.01, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Kevin McKian's median patient age at 67, with 65% women.

Medicare patients, 2024487
Average age74
Average risk score2.01
Also on Medicaid11%

Kevin McKian's Medicare patients by age, 2024

Kevin McKian's Medicare patients by sex, 2024

  • Women29761%
  • Men19039%

Chronic conditions among Kevin McKian's Medicare patients, 2024

  1. High blood pressure75%
  2. High cholesterol75%
  3. Cancer51%
  4. Arthritis50%
  5. Ischemic heart disease35%
  6. Anxiety31%
  7. Diabetes31%
  8. Chronic kidney disease30%

Share of Medicare patients with each condition. A patient can have several.

Kevin McKian's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 67

Patient panel by sex, all payers

  • Women65%
  • Men34%

Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

Kevin P. McKian wrote 1,054 Medicare Part D claims in 2024

In 2024, Kevin McKian wrote 1,054 Medicare Part D claims for 209 patients. 78% of them were for generic drugs. CMS names the drug for 815 of them, across 30 drugs with 11 or more claims each, at $1,636,957 in total drug cost. In 2023, CMS named 732 claims across 26 drugs.

Part D claims, 20241,054
Drugs named by CMS30
Total drug cost$1.6M
Part D patients209

Kevin McKian's Part D claims by kind of drug, 2024

  • Generic824 claims78%
  • Brand-name230 claims22%

Kevin McKian's most prescribed drugs by claims, 2024

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Drug classes CMS tracks in Kevin McKian's Part D claims, 2024

  • Opioids5%54 of 1,054 claims
  • Antibiotics4%37 of 1,054 claims

Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.

Part D claims for drugs CMS names, 2023 to 2024

  • 2023
  • 2024
Claims for drugs CMS names
2023: 7322024: 81511%

Drugs named by CMS: 30 in 2024, 26 in 2023.

See all prescribing by Kevin McKian

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

Kevin P. McKian scored 0 out of 100 in Medicare's MIPS program for 2024

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 0 out of 100 for Kevin McKian for performance year 2024, reported individually. Kevin McKian accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Accepts Medicare assignment
Yes

Kevin McKian's MIPS scores, performance year 2024

  • 0of 100Final score
  • 0of 100Quality
  • 0of 100Promoting Interoperability
  • 0of 100Improvement Activities
  • 0of 100Cost

Each score is out of 100. The final score weighs the categories CMS scored for this clinician.

Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026

For MedTech and pharma teams

Find hematologists and oncologists like Kevin McKian by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Kevin P. McKian has worked on 4 clinical trials

Dmand AI links Kevin McKian to 4 clinical trials, 2 of them phase 2 studies. 3 are still active or recruiting. Conditions studied include Breast Neoplasms, Breast Diseases and Triple Negative Breast Neoplasms. National Cancer Institute (NCI) sponsors the most, 2.

Clinical trials with Kevin McKian by phase

  1. NonePhase 1: no trials
  2. 2Phase 2: 2 trials
  3. 1Phase 3: 1 trial
  4. NonePhase 4: no trials

Conditions in Kevin McKian's trials

  • Breast Neoplasms
  • Breast Diseases
  • Triple Negative Breast Neoplasms
  • Brain Neoplasms

Investigators on the most trials with Kevin McKian

Recent clinical trials with Kevin McKian

Sources: ClinicalTrials.gov (National Library of Medicine); and Dmand AI Research Linkage

Kevin P. McKian received $23,481 in industry payments from 2016 to 2025

CMS Open Payments shows 790 general payments to Kevin McKian from 70 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 66% of the total. Heron Therapeutics, Inc. paid the most, $2,722.

General payments to Kevin McKian by program year, 2016 to 2025

General payments to Kevin McKian by kind, 2016 to 2025

$23.5Kin total
  • Food and beverage$15,58566%
  • Consulting fees$6,25027%
  • Speaker and faculty fees$1,0004%
  • Education$5672%
  • Travel and lodging$790%

Companies that paid Kevin McKian the most, 2016 to 2025

Share is of all general payments to this clinician.

See all payments to Kevin McKian

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Kevin P. McKian graduated from Southern Illinois University School of Medicine

Kevin McKian graduated from Southern Illinois University School of Medicine in 2005.

  1. Medical schoolSouthern Illinois University School of Medicine

Source: Dmand AI Professional Profile Data

Sources for Kevin P. McKian's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data
Primary practice, affiliations and health systemNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice DataDmand AI Affiliation Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab)
Clinical trials and co-investigatorsClinicalTrials.gov (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Industry paymentsOpen Payments (CMS) (opens in a new tab)
Training, board certification and membershipsDmand AI Professional Profile Data
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Kevin P. McKian

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Kevin P. McKian's NPI number?

Kevin P. McKian's NPI number is 1972512853. It was assigned on August 7, 2006, and it is active in the NPI Registry.

What does Kevin P. McKian specialize in?

Kevin P. McKian is a hematologist and oncologist in Rolling Meadows, Illinois. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).

Where does Kevin P. McKian practice?

Kevin McKian practices at 3701 Algonquin Rd, Rolling Meadows, IL 60008. Kevin McKian's primary practice is Northwest Oncology and Hematology SC in Rolling Meadows, Illinois. Dmand AI also links Kevin McKian to 4 hospitals and 1 group practice or clinic.

What is Kevin P. McKian's office phone number?

The practice phone on file for Kevin McKian is (847) 437-3312.

What is Kevin P. McKian's medical license number?

Kevin McKian holds Illinois license 036-127475, one of the licenses on file in 2 states.

Which states has Kevin P. McKian been licensed in?

Dmand AI has state licenses on file for Kevin McKian in Illinois and Minnesota.

Which hospitals is Kevin P. McKian affiliated with?

Kevin McKian is affiliated with Northwest Community Hospital. Dmand AI links Kevin McKian to 4 more hospitals.

What medical group is Kevin P. McKian part of?

Kevin McKian is linked to Northwest Oncology & Hematology.

Does Kevin P. McKian accept Medicare?

Yes. CMS data shows Kevin McKian billed Medicare for 49,181 services in 2024, and Kevin McKian accepts Medicare assignment.

What is Kevin P. McKian's MIPS score?

Kevin McKian's MIPS final score for performance year 2024 is 0 out of 100, reported individually.

Show 7 more questionsShow fewer questions

How many Medicare patients does Kevin P. McKian see?

CMS counts 487 Medicare patients who saw Kevin McKian in 2024, with an average age of 74.

What services does Kevin P. McKian bill to Medicare?

In 2024, Kevin McKian's most billed Medicare services were injected or infused drug (J1439), injected or infused drug (J0185) and injected or infused drug (J1627).

Where did Kevin P. McKian go to medical school?

Kevin McKian graduated from Southern Illinois University School of Medicine in 2005.

What drugs does Kevin P. McKian prescribe most?

In 2024 Medicare Part D data, Kevin McKian's most prescribed drugs by claims were Anastrozole, Xarelto and Prochlorperazine Maleate.

Has Kevin P. McKian received payments from drug or device companies?

CMS Open Payments shows $23,481 in general payments to Kevin McKian from 70 companies from 2016 to 2025. The largest total came from Heron Therapeutics, Inc.

How long has Kevin P. McKian been practicing?

Kevin McKian graduated from medical school in 2005, 21 years ago.

Does Kevin P. McKian do research?

Kevin McKian has worked on 4 clinical trials.

Selling to hematology and oncology practices?

See hematologists and oncologists in Illinois by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)